Is epistaxis listed as a Mounjaro side effect?

No. Nosebleeds are not on the FDA prescribing information for Mounjaro. The most common side effects on the label are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspepsia.

Can Mounjaro cause blood clots?

There is no signal in the tirzepatide trials for venous or arterial clotting events at higher rates than placebo. Rapid weight loss in general is not associated with elevated clot risk, and Mounjaro does not affect coagulation factors directly.

Does Mounjaro cause low blood pressure?

Mounjaro lowers blood pressure as part of weight loss, with average systolic drops of 5 to 7 mmHg at higher doses in the SURMOUNT trials. People on antihypertensive medications may need dose adjustments to avoid going too low.

Can Mounjaro cause iron deficiency?

Mounjaro does not directly impair iron absorption, but reduced food intake from appetite suppression can lower dietary iron. People with heavy menstrual periods, frequent nosebleeds, or known anemia should monitor ferritin during treatment.

Can Mounjaro cause bruising at injection sites?

Mild bruising at the injection site happens occasionally, usually from hitting a small subcutaneous vessel. It is not a sign of a systemic bleeding problem. Rotate injection sites and apply gentle pressure for 30 seconds after the needle comes out.

How long does Mounjaro nausea last?

Most people see nausea peak in the first week after a dose escalation and fade over the following two to three weeks. If nausea persists past four weeks at the same dose, talk to your prescriber about staying at the current dose longer rather than escalating.

Can Mounjaro cause headaches?

Headaches are reported by a small percentage of Mounjaro users, often linked to dehydration from GI side effects or to low blood sugar in people also taking insulin or sulfonylureas. Hydration and reviewing concurrent diabetes medications usually resolves it.

Does Mounjaro cause dry mouth?

Yes, dry mouth is a known effect, partly from dehydration and partly from slowed gastric emptying. The same dryness can extend to nasal mucosa, which is one mechanism behind nosebleeds in some users.

Should I stop Mounjaro if I am getting nosebleeds?

Do not stop on your own. Frequent or heavy nosebleeds on Mounjaro are usually managed by treating dehydration, adding humidification, and reviewing concurrent blood thinners. Stopping a working diabetes or weight loss medication has its own risks.

Can Mounjaro Cause Nose Bleeds?

Summary: Nosebleeds are not listed as a known Mounjaro side effect on the FDA label, but several indirect pathways including dehydration, blood pressure changes, and interactions with blood thinners can plausibly trigger epistaxis in tirzepatide users.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: nosebleeds are not specifically listed on the FDA Mounjaro label as a known side effect ^[1]. That does not mean tirzepatide cannot contribute to one. Several plausible indirect pathways exist, and most of them trace back to side effects that are on the label. If you are getting frequent or heavy nosebleeds on Mounjaro, the medication is probably not the direct trigger. Something it set in motion usually is.

Here is the full picture.

What the FDA label actually says about Mounjaro and nosebleeds

Mounjaro's prescribing information lists adverse reactions reported in clinical trials at rates of 5% or greater versus placebo. Nausea, vomiting, diarrhea, decreased appetite, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, eructation (burping), hair loss, and gastroesophageal reflux disease made that list ^[1]. Epistaxis (the medical term for nosebleeds) is not on it. The SURGEON-1 and SURPASS programs that supported tirzepatide's approval did not flag bleeding from the nasal mucosa as a signal. The SURMOUNT obesity trials did not flag it either ^[2].

So if you are searching for "can Mounjaro cause nose bleeds" because you got one, the package insert will not tell you it is a known reaction. The label is silent on this specifically. That is useful information by itself. It means whatever is happening is not a direct pharmacologic effect of tirzepatide on platelets or vessels, the way you would see warfarin cause bleeding or aspirin cause bleeding. The mechanism, if there is one, is downstream.

The indirect mechanisms that actually matter

Four pathways can connect Mounjaro to a nosebleed without the drug touching your nose directly. Each one is worth understanding because each has its own fix.

Dehydration drying the nasal mucosa

This is the most common indirect route. Mounjaro causes nausea, vomiting, and diarrhea in a significant minority of users. In the SURMOUNT-1 trial, nausea hit 33% of the 15 mg arm, vomiting hit 12%, and diarrhea hit 23% ^[2]. Lose that much fluid through the gut and your total body water drops. The mucous membranes that line the inside of your nose are among the first tissues to dry out when you are even mildly dehydrated.

Dry nasal mucosa cracks. Cracked mucosa exposes the dense network of small blood vessels in Kiesselbach's plexus, the area on the front part of the nasal septum that is responsible for roughly 90% of anterior nosebleeds ^[3]. A sneeze, a finger, dry winter air, forced-air heating, or a cold can be enough to start bleeding once the protective mucus layer is gone.

If your nosebleed coincided with a bad few days of Mounjaro GI side effects, dehydration is the leading suspect.

Blood pressure changes during weight loss

Tirzepatide drops blood pressure as people lose weight. In SURMOUNT-1, the 15 mg group saw systolic blood pressure fall by an average of 7.2 mmHg ^[2]. That is welcome news for someone with hypertension. It is less welcome if that drop unmasks a different problem.

Two scenarios are worth flagging. First, a patient already on antihypertensive medication may now be overtreated. Doses that were appropriate at the higher starting weight push blood pressure too low, which can cause lightheadedness, falls, and in some people fragile vessel rupture during the rebound when they stand or strain. Second, the opposite case: some people, particularly those new to Mounjaro and not yet losing weight, may experience transient blood pressure spikes during episodes of nausea, vomiting, or pain. A sudden BP surge can blow a small nasal vessel.

The takeaway is that the direction of the BP change matters less than the magnitude. If your numbers have moved significantly since starting Mounjaro and you are also getting nosebleeds, your prescriber needs to know.

Interactions with blood thinners (very common in the T2D population)

This is the pathway that gets the least attention and probably matters the most. Mounjaro is approved for type 2 diabetes. The American Diabetes Association recommends low-dose aspirin for secondary prevention of cardiovascular disease in adults with T2D who have established atherosclerotic disease ^[4]. Many T2D patients are also on clopidogrel, a DOAC like apixaban or rivaroxaban, or warfarin for atrial fibrillation, prior stroke, or coronary stents.

None of these antiplatelet or anticoagulant drugs interact with tirzepatide at the pharmacokinetic level. Tirzepatide is a peptide cleared by proteolysis, not by CYP enzymes, so the classic drug interaction concerns do not apply. The problem is that someone on aspirin plus a DOAC who develops dehydration from Mounjaro's GI side effects now has dry, fragile mucosa AND impaired clotting. The bleed itself was always possible. The drug just made the trigger easier to reach.

If you are on any blood thinner, including daily low-dose aspirin or fish oil at high doses, your nosebleed threshold is lower than the general population's. Mounjaro changes the conditions around that threshold rather than the threshold itself.

Rapid weight loss in older adults

Vessels in the nasal mucosa get more fragile with age. Atherosclerotic changes, chronic antihypertensive use, and thinning of the mucosal lining all push older adults toward more frequent nosebleeds at baseline. Rapid weight loss adds two more pressures. The first is fluid shifts as adipose tissue mobilizes. The second is the protein and micronutrient gaps that can develop when caloric intake drops sharply and the diet is not built around adequate protein, vitamin K, vitamin C, and iron.

A 70-year-old losing 18% of body weight over a year on Mounjaro is not in the same physiologic position as a 35-year-old losing the same percentage. The nosebleed risk is higher for the older patient, and the cause is the combination of age plus rate of loss, not the tirzepatide molecule.

Normal incidental nosebleed versus a concerning pattern

One nosebleed is not a medical event. Most people get them. Dry winter air, a forceful nose blow, a finger that wandered, and a cold can each cause one with no underlying problem. The question is whether the pattern has changed since you started Mounjaro.

Feature	Probably incidental	Worth a doctor call
Frequency	Once every few months	Multiple per week or any cluster
Duration	Stops within 10 minutes of pressure	More than 20 minutes despite firm pinch
Volume	A few drops to a teaspoon	Soaks a washcloth or fills a sink
Blood thinners on board	None	Aspirin, clopidogrel, warfarin, DOAC, or daily NSAID
Setting	Dry weather, after a sneeze, after picking	Spontaneous, at rest, no clear trigger
Other symptoms	None	Lightheadedness, bruising, gum bleeding, black stools

If you check any column on the right side, that is the trigger for a conversation with your prescriber. Bring your blood pressure log, your medication list, and a count of how many nosebleeds you have had in the past 30 days. That gives the clinician something to work with rather than a vague "I think Mounjaro is causing nosebleeds."

What to do right now

For the bleed itself, the standard first aid is what works:

Sit up and lean slightly forward. Do not tilt your head back. Tilting sends blood down your throat, which is uncomfortable, makes you nauseous, and hides how much you are actually losing.
Pinch the soft cartilage just below the bony bridge of your nose, firmly, between thumb and index finger. Hold for a full 10 to 15 minutes without checking. Most people release too early.
Breathe through your mouth.
Apply a cold compress to the bridge of the nose if it helps.
Once bleeding stops, do not blow your nose, lift heavy objects, or bend forward for several hours.

For prevention if you are getting them on Mounjaro, the leverage points are all environmental and physiologic:

Run a cool-mist humidifier in your bedroom, especially in heated or air-conditioned rooms. Target 40 to 50% indoor humidity.
Use a saline nasal spray two to three times a day. Plain saline is enough. No medicated spray needed unless your doctor specifically prescribes one.
A thin layer of petroleum jelly or a saline-based nasal gel inside the front of each nostril at bedtime prevents overnight drying.
Stay ahead of fluid intake. If Mounjaro is causing nausea, sip clear fluids constantly rather than waiting until you feel thirsty. Thirst lags behind dehydration.
Avoid forceful nose blowing and aggressive nose picking. Both restart healing bleeds.
Review every medication and supplement with your doctor, including fish oil, vitamin E, ginkgo, and daily aspirin. Any of these can lower the bleeding threshold.

If nosebleeds continue more than twice a week despite humidification and hydration, or if any single nosebleed lasts more than 20 minutes under firm pinch pressure, that is a prescriber call. If you are on a blood thinner, do not stop it on your own. Call the doctor who prescribed it.

A note on the limits of the data

The honest answer to "can Mounjaro cause nose bleeds" is that the evidence base is thin. Tirzepatide is a relatively new molecule, approved by the FDA in 2022 for T2D and 2023 for chronic weight management. Post-market surveillance is ongoing. Epistaxis has not surfaced as a notable signal so far, but rare or indirect adverse events take years to characterize fully. The pathways above are biologically plausible and clinically reasonable to investigate, but no published randomized trial has measured tirzepatide-associated nosebleed rates specifically.

If you have had a clear pattern of new nosebleeds since starting Mounjaro, report it to your prescriber. Reports through MedWatch and FAERS are how new signals get detected after approval. Your data point matters.

Common questions about Mounjaro and bleeding-related side effects

Is epistaxis listed as a Mounjaro side effect?: No. Nosebleeds are not on the FDA prescribing information for Mounjaro. The most common side effects on the label are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspepsia.
Can Mounjaro cause blood clots?: There is no signal in the tirzepatide trials for venous or arterial clotting events at higher rates than placebo. Rapid weight loss in general is not associated with elevated clot risk, and Mounjaro does not affect coagulation factors directly.
Does Mounjaro cause low blood pressure?: Mounjaro lowers blood pressure as part of weight loss, with average systolic drops of 5 to 7 mmHg at higher doses in the SURMOUNT trials. People on antihypertensive medications may need dose adjustments to avoid going too low.
Can Mounjaro cause iron deficiency?: Mounjaro does not directly impair iron absorption, but reduced food intake from appetite suppression can lower dietary iron. People with heavy menstrual periods, frequent nosebleeds, or known anemia should monitor ferritin during treatment.
Can Mounjaro cause bruising at injection sites?: Mild bruising at the injection site happens occasionally, usually from hitting a small subcutaneous vessel. It is not a sign of a systemic bleeding problem. Rotate injection sites and apply gentle pressure for 30 seconds after the needle comes out.
How long does Mounjaro nausea last?: Most people see nausea peak in the first week after a dose escalation and fade over the following two to three weeks. If nausea persists past four weeks at the same dose, talk to your prescriber about staying at the current dose longer rather than escalating.
Can Mounjaro cause headaches?: Headaches are reported by a small percentage of Mounjaro users, often linked to dehydration from GI side effects or to low blood sugar in people also taking insulin or sulfonylureas. Hydration and reviewing concurrent diabetes medications usually resolves it.
Does Mounjaro cause dry mouth?: Yes, dry mouth is a known effect, partly from dehydration and partly from slowed gastric emptying. The same dryness can extend to nasal mucosa, which is one mechanism behind nosebleeds in some users.
Should I stop Mounjaro if I am getting nosebleeds?: Do not stop on your own. Frequent or heavy nosebleeds on Mounjaro are usually managed by treating dehydration, adding humidification, and reviewing concurrent blood thinners. Stopping a working diabetes or weight loss medication has its own risks.

When the nose bleed is the symptom, not the diagnosis

A new pattern of nosebleeds is rarely about the nose. It is about what is happening to the rest of the body. Dehydration, blood pressure shifts, antiplatelet medications, fragile vessels in older patients, and changes in micronutrient status all show up in the nose first because Kiesselbach's plexus is the most exposed vascular bed you have. Mounjaro can create the conditions for that pattern without being the direct cause of the bleed. Fix the conditions and the bleeding usually stops without changing the medication.

If it does not stop, that is the conversation to have with your prescriber. Not "is Mounjaro causing nosebleeds?" but "what has changed in my fluid status, my blood pressure, and my other medications since I started Mounjaro, and what do we do about it?"